other 2026 Umbilical cutaneous endometriosis: a diagnostic challenge Clinical and experimental dermatology ·doi:10.1093/ced/llag028
article 2016 Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies ·doi:10.1016/j.fertnstert.2016.07.780
article 2016 The effect of elagolix on the endometrium: safety results from two randomized, placebo-controlled studies in women with endometriosis-associated pain ·doi:10.1016/j.fertnstert.2016.07.274
article 2016 The impact of elagolix on quality of life in women with endometriosis-associated pain: results from two randomized, placebo-controlled studies using the endometriosis health profile questionnaire ·doi:10.1016/j.fertnstert.2016.07.271
article 2016 Use of elagolix for the management of endometriosis-associated pain: secondary efficacy results from two randomized, placebo-controlled studies ·doi:10.1016/j.fertnstert.2016.07.774